105 related articles for article (PubMed ID: 6754064)
1. Treatment of patients with stages I and II nonmediastinal Hodgkin's disease.
Hagemeister FB; Fuller LM; Sullivan JA; Johnston D; North L; Butler JJ; Velasquez WS; Shullenberger CC
Cancer; 1982 Dec; 50(11):2307-13. PubMed ID: 6754064
[TBL] [Abstract][Full Text] [Related]
2. Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomy.
Hagemeister FB; Fuller LM; Sullivan JA; North L; Velasquez W; Conrad FG; McLaughlin P; Butler JJ; Shullenberger CC
Radiology; 1981 Dec; 141(3):783-9. PubMed ID: 6895415
[TBL] [Abstract][Full Text] [Related]
3. The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results.
Fuller LM; Hagemeister FB; North LB; McLaughlin P; Velasquez WS; Cabanillas F
Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):683-92. PubMed ID: 3280532
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
5. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
6. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
[TBL] [Abstract][Full Text] [Related]
7. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E
NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
[TBL] [Abstract][Full Text] [Related]
8. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
9. Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease.
Zittoun R; Audebert A; Hoerni B; Bernadou A; Krulik M; Rojouan J; Eghbali H; Merle-Béral H; Parlier Y; Diebold J
J Clin Oncol; 1985 Feb; 3(2):207-14. PubMed ID: 3838188
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of long-term survival and treatment complications in children with Hodgkin's disease.
Mauch PM; Weinstein H; Botnick L; Belli J; Cassady JR
Cancer; 1983 Mar; 51(5):925-32. PubMed ID: 6687379
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
[TBL] [Abstract][Full Text] [Related]
12. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
13. The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy.
Rosenberg SA; Kaplan HS
Cancer; 1975 Jan; 35(1):55-63. PubMed ID: 803252
[TBL] [Abstract][Full Text] [Related]
14. Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone.
Givens SS; Fuller LM; Hagemeister FB; Gehan EA
Cancer; 1990 Jul; 66(1):69-74. PubMed ID: 2354411
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
Cramer P; Andrieu JM
J Clin Oncol; 1985 Nov; 3(11):1495-502. PubMed ID: 3903063
[TBL] [Abstract][Full Text] [Related]
16. Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment.
Berkowicz M; Rath P; Aghai E; Many A; Ben-Bassat I; Hulu N; Ramot B; Brenner H
Isr J Med Sci; 1978 Dec; 14(12):1275-82. PubMed ID: 748241
[TBL] [Abstract][Full Text] [Related]
17. A Southwest Oncology Group: chemotherapy versus chemotherapy plus radiotherapy in treatment of stage III Hodgkin's disease.
Grozea PN; De Persio EJ; Coltman CA; Fabian CJ; Morrison FS; Gehan EA; Jones SE
Recent Results Cancer Res; 1982; 80():83-91. PubMed ID: 6173904
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRA.
Nissen NI; Nordentoft AM; Brincker H; Andersen E; Jensen MK; Nielsen JB; Pedersen-Bjergaard J; Jensen TS; Jensen KB; Videbaek A; Pedersen M; Walbom-Jørgensen S
Scand J Haematol; 1980 Jul; 25(1):35-44. PubMed ID: 7003700
[TBL] [Abstract][Full Text] [Related]
19. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
[TBL] [Abstract][Full Text] [Related]
20. Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.
Carde P; Burgers JM; Henry-Amar M; Hayat M; Sizoo W; Van der Schueren E; Monconduit M; Noordijk EM; Lustman-Marechal J; Tanguy A
J Clin Oncol; 1988 Feb; 6(2):239-52. PubMed ID: 2578012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]